![](/img/client_headers/StinsonLeonard/DoddFrankHeader.jpg)
ISS has updated its frequently asked questions on U.S. Proxy Voting Research Procedures & Policies (Excluding Compensation-Related). New and updated questions include:
-
When are ISS’s proxy reports issued?
-
How and when will ISS change a vote recommendation in a proxy alert?
-
How can a company request engagement with the U.S. research analysts?
-
When is the best time to request an engagement?
-
What topics are generally discussed in engagements regarding non-contentious meetings?
-
Is there a blackout period for engagement with research?
-
What exceptions to the attendance policy apply in the case of a newly-appointed director?
-
Proxy access proposals: How will ISS evaluate a Board’s implementation of proxy access in response to a majority-supported shareholder proposal?
-
How will ISS apply the new 2018 policy whose previously-grandfathered poison pills will be expiring shortly?
-
How do companies terminate poison pills prior to the expiration date?
-
Does ISS still consider deadhand or slowhand provisions problematic?
-
What if a company adopts a poison before the company goes public?
-
Removal of Shareholder Discretion on Classified Boards
-
Which types of charter/bylaw adoptions are likely to result in continued adverse voting recommendations?
-
What is the purpose of the Governance Failures Policy?